Julia Novina is a founding executive who helped Microbial Machines secure seed funding and lab space to launch in 2019 and, since that time, has been performing legal and other auxiliary functions for the company. Julia also serves as the Chief Legal Officer of NextRNA Therapeutics, Raqia Therapeutics and AI Proteins, as well as General Counsel of Courage Therapeutics, also overseeing corporate formation, founder and seed rounds of financing, technology licensing, contracting and general company administration. Earlier in her career, Julia was a litigator, primarily in the areas of government contracts and consumer financial services. Before pivoting to her current biotechnology focus, Julia co-owned and ran small businesses and managed commercial real estate.
She earned her JD from the Georgetown University Law Center and graduated magna cum laude from Connecticut College.